AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Spire Healthcare Group PLC

Board/Management Information Sep 5, 2024

5328_rns_2024-09-05_f915e373-6a21-4566-968f-4888c4f1d2be.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 0630D

Spire Healthcare Group PLC

05 September 2024

5 September 2024

Spire Healthcare Group plc

('Spire Healthcare', 'the Company' or 'the Group')

Spire Healthcare Group plc announces the passing of Martin Angle, Deputy Chairman and Independent Non-Executive Director

It is with great sorrow that Spire Healthcare announces that Martin Angle, Deputy Chairman and independent Non-Executive Director of the Company, passed away on Monday, 2 September 2024. Mr Angle served as a member of the Board from March 2019 and was Chair of the Audit and Risk Committee and a member of the Clinical Governance and Safety Committee, Nomination and Remuneration Committees.

Sir Ian Cheshire, Non-Executive Chairman, and Justin Ash, Chief Executive Officer, commented: "It is with deep sadness that we learned of the passing of our dear friend and colleague, Martin Angle, earlier this week. Martin was a highly respected, valued and trusted member of our Board and a personal friend to us both and many others at Spire Healthcare. He will be sorely missed by all who had the privilege of knowing him. Our deepest sympathies and condolences are with Martin's family at this difficult time."

- Ends -

For further information please contact:

Spire Healthcare Group plc

Mantraraj Budhdev - Group General Counsel and Company Secretary

+44 (0)7787 28 38 48

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAUVAWRSAUKRRR

Talk to a Data Expert

Have a question? We'll get back to you promptly.